Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 111 Peter Street Suite 300 Toronto ON M5V2G9 CAN

P: 416-504-0004

Description:

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Key Statistics

Overview:

Market Capitalization, $K 1,445,980
Shares Outstanding, K 375,579
Annual Sales, $ 74,435 K
Annual Net Income, $ -396,107 K
Last Quarter Sales, $ 25,033 K
Last Quarter Net Income, $ -32,638 K
60-Month Beta 1.02
% of Institutional Shareholders 12.77%

Growth:

1-Year Return -63.73%
3-Year Return -80.82%
5-Year Return 135.67%
5-Year Revenue Growth 182.71%

Per-Share Information:

Most Recent Earnings -0.09 on 05/10/22
Next Earnings Date 08/05/22
Earnings Per Share ttm -0.72
EPS Growth vs. Prev Year -89.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRON.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -18.47%
Return-on-Assets % -16.45%
Profit Margin % -532.15
Net Margin % -3.08
Debt/Equity 0.01
Price/Sales 13.36
Price/Book 0.84
Book Value/Share 4.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar